Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study - Wikidata - awgldk - TriplyDB

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study

http://www.wikidata.org/entity/Q34150807

about

The inflammatory protein Pentraxin 3 in cardiovascular disease Cardiac biomarkers: new tools for heart failure management Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial.Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study.Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.Consolidated and emerging inflammatory markers in coronary artery disease Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.Analysis of Clinically Relevant Factors for Pulmonary Hypertension in Maintenance Hemodialysis Patients.Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.Emerging families of biomarkers for coronary artery disease: inflammatory mediators Evaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay population Interesting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients.Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation.Pentraxins in the activation and regulation of innate immunity.Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease.Pepsin-pancreatin protein hydrolysates from extruded amaranth inhibit markers of atherosclerosis in LPS-induced THP-1 macrophages-like human cells by reducing expression of proteins in LOX-1 signaling pathway.Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.Pentraxin-3 level at admission is a strong predictor of short-term mortality in a community-based hospital setting.Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.Relationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease.Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases.PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer.C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques.Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study.Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.

P2860

Q26738957-9E1B6BA4-73B6-4253-B996-78CC204236DE Q26991726-3B012338-610D-4BC7-BD7C-4EF2A127EFD8 Q33744933-A6F29F86-36C0-4629-92DC-396CCBC9D28E Q33748025-83EE065F-1C56-4722-9391-612249243E9F Q33760848-B5513838-3C86-437C-A376-37FE016676B1 Q34579101-250010BE-D372-4D8A-9AA9-BAD3B60E3203 Q34713240-6A104996-8390-4992-A3F0-C721E0955D1F Q35019922-E4B50C04-D689-4E8F-8B7D-D1E4D14ED437 Q35140370-07E35E6C-9C6E-4B1D-907C-650B667C51F1 Q36420463-4C7B0DB9-D525-40CE-B355-1ACB8DC3ABB6 Q36533057-79FE942D-784E-442A-82D8-BDFB029E3E0D Q37115819-50692898-B64C-4A12-91F8-A3FAF35A353A Q37370584-ACBA3D8B-096C-4A4E-BA94-01A9CF7F2C8A Q37629231-4064012F-506B-42AE-A8BE-B7D3276AF72D Q38084920-72D99231-9754-4A34-8C59-0D648275310A Q38386941-4F2D0AFE-A25B-4CF6-8F88-18113E69ED45 Q38901060-788E95F7-DF5D-4BC6-A063-5275C0C392E5 Q38991073-407FE218-ED22-4964-A622-B3FE705E05E6 Q39252622-006090C3-F1A9-445B-852E-3DCB4DD2C663 Q40151204-EBC12154-77BC-49FB-85BA-B081AB1FE92B Q40865321-33737ABC-1B7E-4A1C-9746-FA004DFE8597 Q44605195-C6A4C4EB-F1E4-451C-AF36-1B0D7664A2B8 Q45110914-0DBB5EC5-EF68-4C35-8A2B-BEA34CA9BE06 Q46237239-C1136597-48BD-47AF-B9E0-335CDD617CE5 Q48293075-10EA0536-3FD0-43FE-96F7-A2B83756AC34 Q49942926-5875C5D2-9B77-44D0-B7E7-0CA36C9D5E11 Q50143105-D2570F22-0A41-4D2D-8EAC-8B784FEAB29D Q50277156-C4475524-5F04-4C78-9991-CCF534385994 Q51595971-4FEE6361-42CC-4653-8738-5ECE7DC4F3F9 Q52761490-2147FC8E-B165-4C23-BF65-BF564F4EFEF9

P2860

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study

http://www.wikidata.org/entity/Q34150807

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@ast

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@en

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@nl

type

label

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@ast

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@en

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@nl

prefLabel

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@ast

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@en

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@nl

P1433

Q34150807-A34C134C-9648-46DC-A12D-34068D6590E7

P1476

Q34150807-DB9197C2-9BB0-4A0F-81F6-F2CB0D2AD36B

P2093

Q34150807-344FA337-4088-45DC-B503-AE6524E2F9B0

Q34150807-8C45EFCF-6F8D-40F4-881A-8150BF14B779

Q34150807-B84A533F-7D33-420C-8C89-55CF7E9B3936

P2860

Q34150807-0D87E038-E2F2-4A0D-AE35-102A8FE7AA0A

Q34150807-0E12354A-9934-467D-8C07-21AB92B8C5FE

Q34150807-15D28E39-9747-4BAF-AE4A-CBCD890259AE

Q34150807-1A9AAFF4-0695-453D-B5B7-23104C45F2B7

Q34150807-20907952-CD2C-44AC-9FA8-75E96124AB9D

Q34150807-21CC374F-E95E-4592-9AB9-1B37380BF3FC

Q34150807-37359B88-A228-4019-8E60-CD06E1C0F3A8

Q34150807-49174080-924A-43A9-BAA7-09BAD034118E

Q34150807-493A8770-020B-42F4-A86C-3C7DBAB1FC46

Q34150807-4FFB3E9E-C63C-4951-B13B-A3DD5341E3C0

P304

Q34150807-E57A6A59-9BBD-48DD-A96C-7B6698D476D1

P31

Q34150807-F51158E2-3880-40E5-BAE2-9318D20EDA83

P356

Q34150807-611F86B0-33FA-4F9E-99AA-94B5685E28C6

P407

Q34150807-B9182957-58EB-42DF-A65D-6EAF2D221A16

P433

Q34150807-D83B334C-24DC-49B9-B0BC-899A0A2A76F1

P478

Q34150807-CC604A06-7321-4F06-B1BC-EC43C8C44882

P50

Q34150807-64E36B0B-2EF5-4A12-959E-3A43D988CD19

Q34150807-94B57EEB-CFDA-4AB8-911C-DA208C76C2C2

Q34150807-C7C1DE68-3120-4268-A27B-E1433459A601

P577

Q34150807-568B8DDE-C6D2-44FB-B91F-ABA0B1E46A33

P5875

Q34150807-5F6E95EF-2ECE-46F5-99B1-DEE993A3401D

P698

Q34150807-B8BDE05A-DA30-4CB6-B602-0ED26457B3BB

P921

Q34150807-62129BB8-3590-4A8C-A4D0-C6B1504EFC85

Q34150807-E4DC6DA7-9690-49CF-9E4E-59AA2B44FBDC

P932

Q34150807-8296C4AE-D1E5-47C2-AC1A-3415C61F5A86

P356

J.AHJ.2011.11.007

P1433

American Heart Journal

P1476

Associations of pentraxin-3 wi ...... from the Heart and Soul Study

@en

P2093

Carmen A Peralta

http://www.w3.org/2001/XMLSchema#string

Ruth Dubin

http://www.w3.org/2001/XMLSchema#string

Yongmei Li

http://www.w3.org/2001/XMLSchema#string

P2860

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2

Cystatin C and the risk of death and cardiovascular events among elderly persons

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease

C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.

Production of the long pentraxin PTX3 in advanced atherosclerotic plaques.

Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.

P304

274-279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AHJ.2011.11.007

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P50

Michael G Shlipak

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221806441

http://www.w3.org/2001/XMLSchema#string

P698

22305847

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3273726

http://www.w3.org/2001/XMLSchema#string